Sidra Medicine

What Sidra Medicine does

Sidra Medicine is a private, non-profit academic medical center and member of Qatar Foundation, headquartered in Doha, Qatar, specializing in healthcare for women, children, and young people. Founded in 2016 and JCI Gold Seal-accredited, the institution operates a single full-service hospital campus with outpatient clinics, inpatient care, an emergency department, and specialty services spanning reproductive medicine/IVF, obstetrics, gynecology, menopause, pediatric orthopedics, child and adolescent mental health, developmental pediatrics, and rehabilitation medicine. Its core technology stack integrates a PacBio-certified Central Genomics Unit participating in the Hi-Fi Solves Alliance, a Pediatric Biobank, a CE-marked/FDA-cleared AI-powered X-ray interpretation tool deployed in the Pediatric Emergency Department, and a GMP-compliant manufacturing facility producing autologous serum eye drops and a G-Rex-based CAR-T cell therapy platform for pediatric oncology, supplemented by a Microbiome Service and a Laboratory of Reproductive Biology. Revenue is generated across patient-care services (billed through six insurance partners plus self-pay), medical education programs (Medical Observership Programme, Future Doctor Programme), research grants (e.g., ScaleReady's $100,000 G-Rex Grant), and emerging commercial biologics and microbiome services distributed to academic and industry investigators across the MENA region. The hospital additionally runs international medical convoys, hosts regional conferences (QAPEX 2025, MENA Microbiome Conference 2026), and pursues corporate healthcare partnerships such as the QatarEnergy MoU.

Name

Sidra Medicine

Legal name

Sidra Medicine

Website

https://sidra.org

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Sidra Medicine is a JCI-accredited academic medical center and Qatar Foundation member in Doha, providing specialized clinical care, research, and medical education for women, children, and young people across Qatar and the MENA region.

Ownership category

akta.pro rank

Product category

Academic Medical Center / Specialty Pediatric and Women's Healthcare

NAICS

General Medical and Surgical Hospitals (622110), Offices of Physicians (6211), Health Care and Social Assistance (62)

SIC

Services-Hospitals (8060), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Pediatrics & Adolescent Medicine Practices (HLAFAJAF)

Keywords

• Specialty healthcare services
• Pediatric medicine
• Women's health
• Academic medical center
• Precision medicine

Headquarters

HQ city

Doha

HQ country

Qatar

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Patient Care Services: Revenue generated from hospital services including outpatient clinics, inpatient care, surgical procedures, diagnostic services, and specialized treatments for women, children, and young people. Services include IVF, maternity care, pediatric services, and emergency care.
2. Insurance Billing: Direct billing agreements with insurance companies including QLM, Al-Koot, MSH International, GlobeMed, AP Companies, and LGA Assistance. Also accepts self-paying patients.
3. Medical Education Programs: Revenue from educational programs including the Medical Observership Programme for healthcare professionals and Future Doctor Programme for secondary school students. Certifications accredited by the American Heart Association.
4. Research Grants and Partnerships: External funding through grants such as the $100,000 G-Rex Grant from ScaleReady and collaborative partnerships with organizations like Builders VC MENA for healthcare innovation development.
5. Microbiome Service: Private-paid specialized microbiome testing and analysis service for academic and industry investigators in the MENA region who lack infrastructure to process their samples.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

Core offering

Sidra Medicine provides specialized clinical care for women, children, and young people through three service divisions: Children & Young People's Services (pediatric orthopedics, mental health, rehabilitation, autism services, obesity care), Women's Services (reproductive medicine and IVF, obstetrics, gynecology, menopause), and Adult Services. The institution complements direct patient care with research programs (precision medicine, genomics, Pediatric Biobank, microbiome analysis, CAR-T cell therapy development) and medical education offerings including observerships and fellowships.

Product overview

Sidra Medicine is a JCI-accredited academic medical center and member of Qatar Foundation, providing specialized healthcare services for women, children, and young people in Qatar. The institution operates as a unified hospital offering clinical services organized into three main divisions: Children & Young People's Services (including pediatric orthopedics, mental health, rehabilitation, and specialty programs), Women's Services (including reproductive medicine/IVF, obstetrics, gynecology, and menopause care), and Adult Services. Sidra Medicine's product portfolio includes core clinical services like pediatric obesity care and autism support programs, specialized therapeutic offerings such as the Pediatric Orthopedic Sports Medicine service with growth-sparing techniques, CAMHS mental health services, and Pediatric Rehabilitation Medicine. The organization has launched innovative programs including an AI-powered X-ray interpretation tool for pediatric emergency care, a Microbiome Service for precision medicine, and Qatar's first autologous serum eye drops from its GMP facility. Advanced therapies include the G-Rex CAR-T cell therapy platform for pediatric oncology, sacral neuromodulation for bladder dysfunction, and interventional radiology procedures. Research infrastructure includes a Pediatric Biobank and Precision Medicine Program. Educational offerings include the 'Teach Me How' autism parent program and Future Doctor Program for secondary school students.

Differentiator

Problem solved

Functional benefit

Products and services

• Pediatric Obesity Care Program Comprehensive treatment programs for childhood obesity delivered through a multidisciplinary care model involving pediatricians, endocrinologists, dietitians, psychologists, and other specialists. Includes Qatar's first comprehensive adolescent eating disorders clinic launched in 2025.
• Reproductive Medicine and In Vitro Fertilization (IVF) World-class IVF and fertility services offering conventional IVF, ICSI, PGT, ovulation induction, IUI, and fertility preservation including egg, embryo, and sperm cryopreservation. Uses Matcher electronic witnessing system and Embryoscope time-lapse imaging for embryo selection.
• Pediatric Orthopedic Sports Medicine Specialized pediatric orthopedic sports medicine service delivering growth-sparing surgical techniques for children and young adults with sports-related injuries, including minimally invasive arthroscopic techniques with all-suture anchors that preserve growth plates.
• Child and Adolescent Mental Health Services (CAMHS) Comprehensive mental health services for children and adolescents aged 5 to 18, providing assessment and treatment for autism spectrum disorder, ADHD, anxiety disorders, mood disorders, OCD, and other conditions. Includes outpatient clinic, psychotherapy, medication management, and psychological assessments.
• Microbiome Service Specialized microbiome testing and analysis service supporting precision medicine, clinical research, and personalized healthcare for women, children, and young people. Combines cutting-edge sequencing technologies with multidisciplinary research expertise for academic and industry investigators in the MENA region.
• Autologous Serum Eye Drops Qatar's first autologous serum eye drops - a personalized biologic treatment for severe dry eye conditions. Marks Sidra Medicine's first commercial biologic from the GMP facility, enabling locally produced, high-quality, individualized therapies.
• Pediatric Rehabilitation Medicine Comprehensive rehabilitation services for children with physical disabilities, chronic conditions, or those recovering from serious illness or injury. Includes General Rehabilitation Clinic, Spina Bifida MDT Clinic, and Movement Disorders MDT Clinic offering advanced interventions such as selective dorsal rhizotomy and intrathecal baclofen pump therapy.
• Sacral Neuromodulation Minimally invasive sacral neuromodulation implantation procedure for children with severe bladder dysfunction, including spina bifida patients. Qatar's first pediatric sacral neuromodulation procedure was performed at Sidra Medicine in February 2026.
• AI-Powered X-ray Interpretation Tool AI-powered X-ray interpretation tool integrated into the Pediatric Emergency Department for faster diagnosis and reduced waiting times. CE-marked and FDA-cleared technology that prioritizes potentially urgent cases and improves collaboration between emergency physicians and radiologists.
• Precision Nutrition Research Research programs studying how maternal nutrition affects fetal development through epigenetic changes, including studies linking protein/vitamin/mineral intake to birth outcomes and gestational diabetes associations with dietary fat consumption.
• G-Rex CAR-T Cell Therapy Platform G-Rex centric CAR-T cell therapy platform for pediatric oncology, developed with a $100,000 G-Rex Grant from ScaleReady. Supports creation of a GMP-compliant production system for scalable and cost-effective CAR-T therapy manufacturing.
• Autism Support Services Comprehensive autism care including diagnostic services, the BARAKA genomic study, and the 'Teach Me How' parent empowerment program. Diagnostic wait times reduced from nine to six months under QF Autism Strategy.
• Gynecology Services Comprehensive gynecology care for women of all ages including pediatric and adolescent gynecology, cervical screening and prevention, menopause clinic, and advanced minimally invasive surgeries including robotic and laparoscopic procedures.
• Pediatric Biobank Pediatric biobank storing and documenting biological samples including tissue, blood, urine, saliva, and stool samples to enable scientists to access samples and information for population-specific medical research.
• Precision Medicine Program Personalized healthcare approach considering a patient's genes, environment, and lifestyle to provide tailored care, including genomic diagnosis, early intervention for genetic conditions, and access to innovative treatments.
• Interventional Radiology Services Minimally invasive interventional radiology procedures including endovascular embolization for AVM treatment, utilizing catheter-based techniques through small incisions for targeted therapy with quick recovery times.
• Teach Me How Program Comprehensive educational program on Autism Spectrum Disorder (ASD) designed to empower parents and caregivers with knowledge and skills to support their neurodiverse children through interactive sessions with developmental pediatrics experts.

Quantifiable outcome

• Reduced diagnostic wait times from nine to six months for autism
• +3 more outcomes

Named customers5 records

Segments6 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature8 records

Partnerships

Nine partnerships are on record, tiered minor and core.

• World Innovation Summit for Health (WISH)minorStrategic or Co-development Partner · 28 June 2026WISH is an initiative under Qatar Foundation convening global healthcare leaders. Sidra Medicine participates in the summit focusing on themes including AI in human-centred health, with Dr. Sunoor Verma highlighting gaps between scientific innovation and patient access.
• Dr. Tariq Al-Shaiji (Consultant Urologist, Kuwait)minorStrategic or Co-development Partner · 15 April 2026Collaborated with Dr. Tariq Al-Shaiji from Kuwait for Qatar's first pediatric sacral neuromodulation procedure. Dr. Al-Shaiji brought extensive experience in sacral neuromodulation to support the introduction of this procedure at Sidra Medicine for children with bladder dysfunction.
• QatarEnergycoreStrategic or Co-development Partner · 24 February 2026Sidra Medicine and QatarEnergy signed a Memorandum of Understanding to establish a framework for collaboration in healthcare services, professional development, and expertise exchange. The agreement covers commercial healthcare solutions including insurance pathways and tailored maternity and corporate healthcare packages, as well as continuing medical education and clinical service coordination for QatarEnergy employees. The partnership aims to strengthen Qatar's healthcare ecosystem.
• Builders VC MENAcoreStrategic or Co-development Partner · 5 February 2026Sidra Medicine signed a memorandum of understanding with Builders VC MENA to strengthen collaboration in healthcare innovation and support the development of medical technologies through public-private partnerships. The agreement combines Builders VC's investment expertise and portfolio network with Sidra Medicine's research-driven ecosystem and clinical infrastructure to advance biotech and health-tech solutions. The partnership aims to create tangible healthcare innovations benefiting Qatar and beyond.
• Hi-Fi Solves AlliancecoreStrategic or Co-development Partner · 4 December 2025Sidra Medicine joined the Hi-Fi Solves Alliance, a global consortium advancing long-read genomic sequencing technologies to improve rare disease diagnosis. As part of this, Sidra Medicine's Central Genomics Unit became a PacBio-certified service provider, reinforcing Qatar's position as a regional hub for AI-driven genomic medicine and precision healthcare innovation.
• Qatari Business Women's Association (QBWA)minorGTM or Marketing Partner · 11 October 2025Sidra Medicine and the Qatari Business Women's Association signed a Memorandum of Understanding in Doha to promote women's advancement and health. The partnership aims to share expertise, create opportunities, and support women in business, healthcare, and the broader community.
• Qatar Red Crescent Society (QRCS)minorStrategic or Co-development Partner · 9 October 2025Qatar Fund for Development funded a seven-day medical convoy in Guyana led by Qatar Red Crescent Society, involving medical teams from Hamad Medical Corporation and Sidra Medicine to perform complex surgeries and consultations. Sidra Medicine contributed medical professionals for the humanitarian mission.
• ScaleReadycoreTechnology or Integration · 5 August 2025ScaleReady awarded a $100,000 G-Rex Grant to Sidra Medicine for developing a G-Rex centric CAR-T cell therapy platform for pediatric oncology. The grant enables development, validation, and implementation of GMP-compliant semi-automated G-Rex manufacturing system for scalable and cost-effective CAR-T therapy production. ScaleReady collaborated with Wilson Wolf Manufacturing, Bio-Techne Corporation, and CellReady on this grant.
• Middle East Fertility Society (MEFS)minorStrategic or Co-development Partner · 3 November 2024Sidra Medicine partnered with MEFS for its 31st Annual Scientific Meeting on Fertility Care. The strategic partnership supports knowledge exchange and collaboration in reproductive medicine across the Middle East region.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• King Faisal Specialist Hospital and Research Centre: Saudi Arabia's flagship specialty and academic medical center with deep pediatric, oncology, and research programs. Closest GCC analog to Sidra's combined clinical-research-academic model at a larger national scale.
• Cleveland Clinic Abu Dhabi: US-branded academic medical center in the UAE offering advanced specialty care across multiple disciplines. Comparable to Sidra as a regionally leading tertiary hospital with international affiliations and research ambitions.
• Boston Children's Hospital: Global benchmark pediatric academic medical center. Comparable to Sidra in combining subspecialty pediatric care, genomics/precision medicine, and translational research; serves as the model for many of Sidra's recruitment and capability choices.
• Great Ormond Street Hospital for Children (GOSH): UK-based pediatric specialty hospital renowned for complex care, rare diseases, and research. Directly comparable in mission, clinical complexity, and international patient mix.
• The Hospital for Sick Children (SickKids): Toronto pediatric academic medical center with leading precision medicine and genomics programs. Comparable to Sidra on pediatric specialty depth and integration of research with clinical care.
• Children's National Hospital: Washington DC pediatric academic center; Sidra's mental health leadership previously worked there. Comparable on pediatric specialty breadth, mental health, and research-driven care models.
• Mayo Clinic: US-based global academic medical system. Comparable to Sidra on precision medicine, integrated diagnostics, and complex specialty care, though at vastly greater scale and geographic reach.

Direct peers

• Hamad Medical Corporation: Qatar's largest public healthcare system and Sidra's primary domestic counterpart. Both operate as major hospital systems in Doha serving overlapping patient populations, with HMC handling adult and broader services while Sidra focuses on women, children, and research.

Regional players

• Saudi German Hospital Group: Large private hospital group across the Middle East. Comparable as a regional multi-specialty provider competing for the same MENA patient flows that Sidra targets via its global patient services.
• Mediclinic Middle East: Major private hospital operator in the UAE and broader MENA. Comparable as a regionally scaled private hospital chain competing for cross-border specialty patients, though with a broader adult focus than Sidra's pediatric/women's niche.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/sidramedicine

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds1 record

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sidra Medicine